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Intermediate Filaments—The Basics
(Cyto)-Keratins are structural proteins of epithelial cells that
can be divided into two subgroups, type 1 and type 2 kera-
tins, based on biochemical properties such as molecular
weight and isoelectric point. In vitro and in vivo, type 1 and
type 2 keratins polymerize to form hetero-polymeric inter-
mediate filaments (IF). IF are abundant in stratified epithelia,
in particular the suprabasal layers of the epidermis. They
connect to desmosomes (Cheng and Koch, 2004) at cell–
cell junctions, and to hemidesmosomes (Nievers et al, 1999)
at the interface of epidermis and dermis, establishing a
three-dimensional network of fibrous proteins that cross the
epidermis. It is widely accepted that IF are indispensable
for the normal development and maintenance of stratified
epithelia. Furthermore, animal models have established a
cause–effect relationship between mutations in epidermal
keratin and cell fragility disorders. Often, keratin missense
mutations lead to a collapse of the IF network that causes
cytolysis in response to even minor mechanical stress. In
humans, f.i., mutations in the epidermal keratins K14 can
lead to epidermolysis bullosa simplex, whereas mutations in
K10 can lead to epidermolysis hyperkeratosis (for a more
detailed discussion of the various keratin disorders, see
Irvine and McLean, 1999).
Is there more to keratins than just providing
mechanical resilience to stratiﬁed epithelia?
Several observations suggest that keratins might be more
than just structural reinforcement; first, mammals maintain a
large set of keratin genes. A recent survey of publicly avail-
able human genome sequences identified 27 type 1 and
27 type 2 keratin genes, clustered on chromosomes 17 and
12, respectively (Hesse et al, 2004). Secondly, these
genes show cell type- and differentiation pathway-specific
expression patterns.
Both observations suggest that individual keratins might
have cell type-specific functions. The classical example of
skin keratin pairs with tightly controlled expression patterns
are K5/K14 and K1/K10. K5/K14 are expressed in the basal
layer of the epidermis that contains epidermal stem cells
and transient amplifying (TA) cells. K1/K10, on the other
hand, are synthesized only in post-mitotic keratinocytes
and are, consequently, found in the suprabasal layers of the
epidermis.
Transgenic mouse experiments by Pierre Coulombe’s
group have shown that loss of an epidermal keratin (K14)
cannot be completely compensated by the ectopic expres-
sion of other keratins (Hutton et al, 1998; Paladini and Cou-
lombe, 1999), supporting the view that each keratin pair has
evolved to specifically meet the needs of a particular cell
type.
Cell Proliferation and Susceptibility to
Tumor Formation—Keratinocyte Properties
Affected by Keratin 10?
In a series of publications, the Jorcano laboratory has pro-
posed that keratins might affect keratinocyte proliferations,
and the susceptibility of these cells to tumor formation (re-
viewed in Paramio and Jorcano, 2002). These experiments
focused on keratin 10, which is normally expressed only in
post-mitotic keratinocytes. The Jorcano group used kera-
tinocyte transfection assays (Paramio et al, 1997, 1999;
Paramio and Jorcano, 2001) and transgenic mice that ex-
pressed K10 under the control of a bovine K5 promoter in
the basal layer of the epidermis in their studies (bK5.K10,
Santos et al, 2002a, b; 2003). Their results suggested that
ectopic expression of K10 prevents cell cycle progression
of basal keratinocytes. Using keratinocyte transfection as-
says, they also showed that K16 expression can rescue
K10-mediated cell cycle arrest (Paramio et al, 1999). This
fits very well with the expression patterns of these two
keratins in normal and wounded skin, respectively. K16 is
usually not expressed in the interfollicular epidermis. Upon
wounding, K10 expression is downregulated and K16 up-
regulated, which has been interpreted as a means to allow
proliferation and migration of keratinocytes necessary to
repair cutaneous wounds.
By using a combined genetic and chemical carcinogen-
esis protocol, Jorcano’s group showed that bK5.K10
transgenic mice were less susceptible to tumor formation,
i.e. developed fewer and smaller tumors later than controls,
and showed less conversion of papillomas to squamous cell
carcinomas (SSC, Santos et al, 2002b). All of these obser-
vations are in accordance with the well known changes in
keratin expression patterns observed when benign pap-
illomas convert to SSC and spindle cell carcinomas (e.g.,
Nischt et al, 1988; Roop et al, 1988; Wang et al, 1998). K10Abbreviation: IF, intermediate filament
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is one of the first marker proteins that is lost during malig-
nant conversion.
The studies summarized above suggest a sequence of
events in which K5/14-expressing TA cells induce expres-
sion of K10, which then inhibits cell cycle progression and
commits the cell to terminal differentiation.
Nevertheless, a study published by Reichelt and col-
leagues in this issue of the JID suggests that it might not be
as simple as that. Instead of using ectopic expression of
K10 in cells that do not synthesize this protein in vivo, they
analyzed mice with a K10 null mutation (Reichelt et al, 2001;
Reichelt and Magin, 2002). In these mice, basal keratin-
ocytes express the normal complement of keratins (K5/
K14), and this IF network appears to partially compensate
for a loss of the suprabasal K1/K10 cytoskeleton. Keratin-
ocyte hyperproliferation was observed in these mice, how-
ever, it was restricted to the basal cell layer.
Although K10 expression in basal keratinocytes might
suppress proliferation, loss of K10 expression does not ap-
pear to be sufficient to allow suprabasal cells to re-enter the
cell cycle. What about tumor susceptibility? Reichelt et al
(2004) report that the K10 null mice do not show sponta-
neous tumor formation. To further analyze tumor suscepti-
bility, these authors used a well-established two-stage
chemical carcinogenesis protocol on their mice. The sur-
prising finding was that the K10 null mice developed less
papillomas per mouse than wild type controls. Furthermore,
there was no significant difference conversion of papillomas
to SSC. Reichelt and colleagues also provided an explana-
tion for the reduced number of tumors in K10 null mice: The
turnover of keratinocytes is increased in these mice, i.e.,
basal keratinocyte reach the skin surface and are shed into
the environment much faster than wild-type cells. The au-
thors suggest that the reduced transition time might reduce
the pool of cells that accumulate enough genetic damage to
convert to tumor cells.
Where Do We Stand?
The work outlined above highlights the fact that the type of
IF cytoskeleton assembled in an epithelial cell can influence
basic cell properties such as the ability to divide. The ob-
served increase in the turnover of the epidermis raises the
question of whether keratinocyte migration and/or cell de-
tachment from the basement membrane are increased in
the K10 null epidermis.
Skin cancer most likely develops as a result of genetic
alterations that accumulate in epidermal stem cells. If Re-
ichelt et al, are correct in their assumption that increased
epidermal turnover is responsible for the reduced tumor in-
cidence, one would have to assume that K10 null mice
show accelerated stem cell depletion. As a consequence of
this, one would expect to see the development of sponta-
neous phenotypes such as skin erosions that fail to heal, as
was observed in another mouse model which exhibited an
accelerated depletion of stem cells due to deregulated ex-
pression of c-Myc (Waikel et al, 2001). Interestingly, Reichelt
and colleagues previously observed overexpression of c-
Myc in the basal layer of K10 null mice (Reichelt and Magin,
2002), but to our knowledge they have not observed phe-
notypes with aging that would be associated with stem cell
depletion.
The work by Reichelt and colleagues clearly shows that
K10 is not a tumor suppressor gene, as suggested before.
Nevertheless, the finding that loss of the normal K1/K10 IF
network affects transit time and cell proliferation (although
in trans) needs to be followed up and promises to provide
new insights into keratinocyte differentiation.
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